TY - BOOK ID - 100014318 TI - Vaccines, medicines and COVID-19 : how can WHO be given a stronger voice? PY - 2022 SN - 3030891259 3030891240 PB - Cham : Springer International Publishing : Imprint: Springer, DB - UniCat KW - COVID-19 (Disease) KW - Medical policy. KW - Vaccines. KW - Social aspects. KW - 2019-nCoV disease KW - 2019 novel coronavirus disease KW - Coronavirus disease-19 KW - Coronavirus disease 2019 KW - COVID-19 virus disease KW - COVID19 (Disease) KW - Novel coronavirus disease, 2019 KW - SARS coronavirus 2 disease KW - SARS-CoV-2 disease KW - Coronavirus infections KW - Respiratory infections KW - Biologicals KW - Health care policy KW - Health policy KW - Medical care KW - Medicine and state KW - Policy, Medical KW - Public health KW - Public health policy KW - State and medicine KW - Science and state KW - Social policy KW - Government policy KW - COVID-19 Coronavirus pandemic KW - access to affordable essential medicines KW - Vaccine nationalism and vaccine safety KW - World Health Organization reform KW - Biosimilars and biotherapeutics KW - COVAX Facility KW - COVID-19 diagnostics KW - Global health preparedness KW - Article 19 of the WHO Constitution KW - access to COVID-19 tools (ACT) accelerator KW - Framework Convention on Tobacco Control (FCTC) KW - Inter-Governmental Working Group (IGWG) KW - Patentability criteria KW - Pharmaceutical sovereignty KW - Research and Development (R&D) KW - Universal Health Coverage (UHC) KW - World Health Assembly (WHA) KW - World Trade Organization (WTO) KW - non-governmental organization (NGOs) KW - Open Access KW - Medicine, Preventive. KW - Health promotion. KW - Vaccines KW - Biomaterials. KW - Public health. KW - Health Promotion and Disease Prevention. KW - Health Policy. KW - Biomaterials-Vaccines. KW - Public Health. KW - Biotechnology. KW - Community health KW - Health services KW - Hygiene, Public KW - Hygiene, Social KW - Public health services KW - Public hygiene KW - Social hygiene KW - Health KW - Human services KW - Biosecurity KW - Health literacy KW - Medicine, Preventive KW - National health services KW - Sanitation KW - Vaccine biotechnology KW - Biotechnology KW - Health promotion programs KW - Health promotion services KW - Promotion of health KW - Wellness programs KW - Preventive health services KW - Health education KW - Disease prevention KW - Diseases KW - Prevention of disease KW - Preventive medicine KW - Pathology KW - Preventive medicine physicians KW - Prevention KW - COVID-19 Pandemic, 2020 KW - -Political aspects. UR - https://www.unicat.be/uniCat?func=search&query=sysid:100014318 AB - This open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. In this single volume, the chapters present the progress of thinking and debate — particularly in relation to drugs and vaccines — that would enable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered: COVID-19 Vaccines: Between Ethics, Health and Economics Medicines and Intellectual Property: 10 Years of the WHO Global Strategy Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock Intellectual Property and Access to Medicines and Vaccines The World Health Organization Reforms in the Time of COVID-19 Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19. ER -